GARDASIL
MERCK
Identification
- Active ingredient (INN)
- VACCIN PAPILLOMAVIRUS HUMAIN (TYPES 6,11,16,18,31,33,45,52,58) RECOMBINANT,ADSORBE
- Internal code
- 13 U 531
- Country of Origin
- Netherlands
- Pharmaceutical form
- Injectable Suspension (Pre-filled Syringe)
- Prescription List
- Highly Regulated (List I)
- Packaging
- b/01 seringue preremplie et 02 aiguilles
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Description
Human papillomavirus type 6 L1 capsid protein antigen is contained in Gardasil, or a recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) vaccine for intramuscular injection.
It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus (HPV) types and 18.
The vaccine is prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, and 18, which are produced by separate fermentations in recombinant Saccharomyces cerevisiae and self-assembled into VLPs.
Indications
Not Available
Adverse Effects
Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.